Meeting the workforce needs of the Georgia life science ecosystem: 3 minutes with Georgia BioEd Board Chair Philip Gibson

The future of a state’s life science industry is only as bright as its workforce pipeline. Careers in the life sciences are often born from simple demonstrations of how things like the heart work (a tennis ball and a bit of latex will do) and parent education on what the life science industry can offer students.

Philip Gibson, Georgia BioEd Board Chair talks about about its mission, work and industry ties.

“[One of] Georgia BioEd’s needs is [more] participation of the industry to help us to determine what exactly do they want out of someone that’s coming out of the educational system,” Philip said. “What do they desire in employees, how many employees do they need? We work to generate that information and then to try to meet those needs of the state.”

 

 

If you would like to know more about how Georgia Bio supports the state’s life science workforce and educator needs, contact email Senior Director of Member Engagement Kristina Forbes via email: kforbes@gabio.org .

Follow Georgia Bio on LinkedIn , Twitter and Facebook.

September 11, 2025
Members are invited to join G2G’s Monthly GBG Reporting Service Webinar on September 18, 2025 . The first portion ( 12:00–12:30 PM ET ) is free and open to all, offering a high-level overview of current federal funding trends. The second half ( 12:30–1:00 PM ET ) is a premium consultation available only to Georgia Life Sciences members, offering direct access to G2G’s expert team—who have helped secure over $550 million in non-dilutive government funding since 2007. Register here: https://www.g2gconsulting.com/event/non-dilutive-funding-g2gs-monthly-gbg-reporting-service-webinar-14-3/2025-09-18/ Key opportunities this month include DARPA’s Expedited Research Innovation System for CBRN threat defense technologies, BARDA’s I-CREATE diagnostic funding and VANGUARD biomanufacturing tools development (each offering up to $200,000), NIAID tuberculosis and influenza research units (up to $1.5–$2.5 million annually), DoD’s $4 million Advanced Medical Monitor development through MTEC, and multiple SBIR opportunities for sensors and field-deployable diagnostics (up to $209,575 for Phase I awards). The September GBG report highlights 13 immunology and infectious disease opportunities, 10 cognitive and brain health programs, and several biotechnology and biomanufacturing initiatives across federal agencies including the Army, ARPA-H, BARDA, and NSF. Georgia Life Sciences members can access the complete 29-page report with detailed deadlines and eligibility requirements [insert link or portal instructions here]. GLS members can access the full 29-page report with deadlines and submission details by logging into your member portal.
By Maria Thacker Goethe September 5, 2025
Protecting U.S. Leadership in Agricultural Biotechnology
By Maria Thacker Goethe August 29, 2025
Celebrating the Next Generation of Scientific Breakthroughs in Georgia
MORE POSTS